Israel Englander’s Biohaven BHVN Stock Holding History

Israel Englander’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-400,000	Closed	-$6M	–	6018
2025 Q3	$6M	Sell	400,000 -380,000	-49%	-$5.53M	﹤0.01%	2947
2025 Q2	$11M	Buy	+780,000	New	+$13.9M	0.01%	2166
2025 Q1	–	Sell	-65,000	Closed	-$2.43M	–	5870
2024 Q4	$2.43M	Buy	65,000 +10,000	+18%	+$467K	﹤0.01%	3473
2024 Q3	$2.75M	Buy	+55,000	New	+$2.14M	﹤0.01%	3401
2024 Q2	–	Sell	-25,000	Closed	-$1.37M	–	5896
2024 Q1	$1.37M	Buy	25,000 +3,300	+15%	+$163K	﹤0.01%	4043
2023 Q4	$929K	Buy	+21,700	New	+$675K	﹤0.01%	4219
2023 Q3	–	Sell	-89,100	Closed	-$2.13M	–	6128
2023 Q2	$2.13M	Buy	89,100 +9,100	+11%	+$157K	﹤0.01%	3431
2023 Q1	$1.09M	Buy	+80,000	New	+$1.27M	﹤0.01%	4007
2022 Q4	–	Sell	-139,844	Closed	-$20.7M	–	6574
2022 Q3	$20.7M	Buy	+139,844	New	+$1.01M	0.01%	1317

Other funds holding BHVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Israel Englander's BHVN Position: Q2 2026 in Review

Israel Englander reduced its Biohaven (BHVN) stake by 71% in Q2 2026, selling an estimated $11.1M and leaving 417,534 shares worth $6.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2786.

Israel Englander first reported a position in BHVN in Q3 2022 and has held it in 12 quarters since. The position peaked at $153M in Q3 2022. 291 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

Israel Englander held 417,534 shares of Biohaven worth $6.21M as of Q2 2026.
Israel Englander sold 1,030,352 Biohaven shares in Q2 2026, an estimated $11.1M.
Biohaven made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2786 holding.
Israel Englander first reported a position in Biohaven in Q3 2022 and has held it in 12 quarters since.
Israel Englander's Biohaven position peaked at $153M in Q3 2022.
291 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.